Through the Avature system, the undersigned has access to confidential data relating to associates of Novartis or Sandoz as well as external applicants (e.g. personal information, CV's Candidate profile, etc.). The undersigned herewith undertakes to handle this personal information in strict confidence and to keep the information absolutely secret in respect of third parties. They shall only use such data to fulfill the professional duties with which they have been entrusted. It is permitted to pass on such information to persons within Novartis who require the data in order to fulfill their professional duties. Assessments, reports and data extracts may only be passed on to persons who can show that they are authorized to receive these data. In cases of doubt, the superior shall be consulted. At the workplace, all the necessary precautions shall be taken to ensure that unauthorized persons cannot gain access to confidential data. All documents and data carriers relating to personal data are to be returned as soon as a job is completed. Failure to meet these obligations may result in criminal proceedings.

Unauthorized modification or deletion of data, rendering of data unusable, or fraudulent misuse of a data processing system is likewise liable to prosecution in the courts. This obligation of secrecy also remains effective after a transfer to a different department and after leaving the company.

1. Novartis or Sandoz and Contractor undertake to keep confidential and not use or disclose to any third party, all information received from the other party, and to take all reasonable measures to comply with such obligations. Neither party shall use such information disclosed to for its own behalf or the benefit
2. Any party receiving information from the other party under the Agreement shall hold in confidence any and all such information, except:
·information which at the time of disclosure is in the public domain;·information which, after it is disclosed, becomes part of the public domain by publication or otherwise, except by breach of this Agreement by the receiving party;
·information which the receiving party can establish by competent proof was in its possession at the time of disclosure by the other party and was not acquired, directly or indirectly, from the other party
·information which the receiving party may receive from a third party who is under no obligation of confidence to the other party;
·information which is independently developed by an employee of the receiving party who has not had access to information supplied by the other party.
Nothing in this confidential Agreement shall prevent the disclosure of information to the proper agencies that is required by law to be disclosed to enable a party to carry out the objectives of the project.
3. Novartis or Sandoz and Contractor company may disclose information, data and documents to those employees and/or third parties who need to know the information for the purposes of this Agreement under the condition that these employees and/or third parties are bound by confidentiality obligations no less strict than those set out hereunder.
4. Obligations under Article 1 will expire ten (10) years after the date of the Agreement or ten (10) years after the disclosure, whichever is the later.
5. Press releases concerning the contract require prior approval by Novartis.
6. Novartis reserve the right to audit the compliance of the Contractor with the Agreement stated in the service contract.
7. Swiss laws apply. Court of law: Basel, Switzerland.